About this trial
The ambition of the project is to help with the primal colonisation of babies born by caesarean section and to improve the lipid composition of an infant formula, in order to reduce the short- and long-term health problems associated with caesarean births. This population, which represents around 20% of babies born in France, has not yet received any specific care to date.
The study aims to develop an optimized infant formula. It includes: (1) isolation of probiotics from breast milk from nursing mothers and stool samples from their babies born vaginally, (2) formulation of an improved milk enriched with physiological lipids and selected probiotics, and (3) preclinical evaluation of its beneficial effects in a cesarean birth model.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
Under the age of 18
Breastfeeding for 6 months or more
Having been on antibiotic therapy in the 6 months prior to sampling
Having taken probiotics in the 6 months prior to sampling
Trial population
Breastfeeding mothers and their babies under 6 months old
Trial design
Case-only
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Measurement of the viability of supplemented probiotic microorganisms (CFU/g) and levels of bioactive lipids in the experimental infant formula specifically designed for cesarean-born infants
Sponsors and contacts
Click on the lead sponsor to view all of their trials.